Trial intelligence / Profile preview

Ketoprofen HBF gel vs Profenid gel in benign joint injury

2004-001239-42Phase 3Completed

Sponsor
APIGENEX s.r.o.
Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ketoprofen in sprain and Joint contusion (2 arms), sponsored by APIGENEX s.r.o. Primary endpoint: number of patients cured without ADRs. Started Jun 2005; status: completed.

02

Drugs

ketoprofen
03

Conditions

sprainJoint contusion

Beyond the preview

Go deeper on 2004-001239-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001239-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call